Researchers reveal a strategy for next-generation COVID-19 vaccines
- Details
- Category: Research
The team’s key criteria for antibodies generated by future vaccines are to target regions of the SARS-CoV-2 viral surface that are unlikely to mutate and share key features that the researchers found could block the virus from infecting human cells.
A commonly found parasite could treat certain types of cancer
- Details
- Category: Research
The research, published today in the Journal for ImmunoTherapy Cancer, was carried out by experts from the University of Nottingham, Ningbo University and Shanxi Agricultural University in China.
Rice web server helps identify COVID-19 drug candidates
- Details
- Category: Research
Lydia Kavraki, a computer scientist at the George R. Brown School of Engineering, and her colleagues at the University of Houston, the University of Edinburgh, Scotland, and the Federal University of Ceará, Brazil, have posted a "user-friendly" web server offering scientists the chance to screen their drug candidates virtually in relation to known protein binding pockets on the SARS-CoV-2 virus.
Needle-free COVID-19 vaccine shows promise
- Details
- Category: Research
The University of Texas Hexapro vaccine candidate - delivered via the UQ-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) - provided protection against COVID-19 disease with a single, pain-free 'click' from a pocket-sized applicator.
New computer modelling could boost drug discovery
- Details
- Category: Research
The computer modelling tool will predict novel sites of binding for potential drugs that are more selective, leading to more effective drug targeting, increasing therapeutic efficacy and reducing side effects.
Horse hyperimmune antibody may help the fight against COVID-19
- Details
- Category: Research
Common antidepressant should no longer be used to treat people with dementia
- Details
- Category: Research
The research, led by the University of Plymouth and published in The Lancet, has shown that antidepressant mirtazapine offered no improvement in agitation for people with dementia - and was possibly more likely to be associated with mortality than no intervention at all.
More Pharma News ...
- High effectiveness of mix-and-match COVID-19 vaccines
- One coronavirus vaccine may protect against other coronaviruses
- Vaccines effective against most SARS-CoV-2 variants
- Scientists discover a highly potent antibody against SARS-CoV-2
- mRNA COVID vaccines highly effective at preventing symptomatic infection in health workers
- How to develop new drugs based on merged datasets
- New drug combination effective against SARS-CoV-2 infection